In addition, immunohistochemistry (IHC) staining data acquired from the HPAD also confirmed the differential expression of the predicted genes (CD48, P2RY10, RASAL3) in sarcoma samples (Additional file 14: Figure S12). This evidence concerns the gene P2RY10 and sarcoma.